Kiniksa Pharmaceuticals International, plc
KNSA · Healthcare · $4.7B
After-hours $63.36+0.49%
Price
$43.05
$63.05
Apr 23, 26Jul 23, 26
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue$227M+5.7%
Operating Income—
Net Income—
3/'26 vs prev quarter
Company Health
Operating Margin+12.4%
Cash on Hand$468M
PSR6.3x
PER64.9x
PBR7.8x
ROE+12.1%
Short Float4.4%biweekly · settled 26.05.15
